Invention Grant
- Patent Title: Antibodies specific to FcRn
-
Application No.: US15036209Application Date: 2014-11-12
-
Publication No.: US10273302B2Publication Date: 2019-04-30
- Inventor: Paul Alan Atherfold , Thomas Allen Ceska , Helene Margaret Finney , Lara Kevorkian , Kaushik Sarkar , Bryan John Smith , Kerry Louise Tyson
- Applicant: UCB BIOPHARMA SPRL
- Applicant Address: BE Brussels
- Assignee: UCB Biopharma SPRL
- Current Assignee: UCB Biopharma SPRL
- Current Assignee Address: BE Brussels
- Agency: Saul Ewing Arnstein & Lehr LLP
- Agent Doreen Y. Trujillo
- Priority: GB1320066.2 20131113
- International Application: PCT/EP2014/074409 WO 20141112
- International Announcement: WO2015/071330 WO 20150521
- Main IPC: C07K16/00
- IPC: C07K16/00 ; C12P21/08 ; A61K39/395 ; A61K39/40 ; C07K16/28 ; A61K47/60 ; A61K47/68 ; A61K39/00
Abstract:
The disclosure relates to antibodies specific to FcRn, formulations comprising the same, use of each in therapy, processes for expressing and optionally formulating said antibody, DNA encoding the antibodies and hosts comprising said DNA.
Public/Granted literature
- US20160264668A1 ANTIBODIES SPECIFIC TO FCRN Public/Granted day:2016-09-15
Information query
